Ilya M Rachman insider trades: Immix Biopharma (IMMX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ilya reports to the SEC
Open-market buys and sales
8 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 10, 2025 | IMMX | ↑ Buy | 746 | $6.67 | $5K | Direct | Dec 10, 2025 (0d) |
| Sep 17, 2025 | IMMX | ↑ Buy | 2,500 | $2.02 | $5K | Direct | Sep 17, 2025 (0d) |
| Jun 18, 2025 | IMMX | ↑ Buy | 2,178 | $2.29 | $5K | Direct | Jun 20, 2025 (2d) |
| Jun 7, 2024 | IMMX | ↑ Buy | 2,600 | $2.13 | $6K | Direct | Jun 10, 2024 (3d) |
| Jun 4, 2024 | IMMX | ↑ Buy | 3,300 | $1.81 | $6K | Direct | Jun 5, 2024 (1d) |
| May 14, 2024 | IMMX | ↑ Buy | 4,300 | $2.25 | $10K | Direct | May 14, 2024 (0d) |
| Nov 14, 2022 | IMMX | ↑ Buy | 5,200 | $1.00 | $5K | Direct | Nov 15, 2022 (1d) |
| Dec 20, 2021 | IMMX | ↑ Buy | 2,500 | $5.00 | $13K | Direct | Dec 20, 2021 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMMX insiders
Open-market trades in the last 12 months
About Ilya M Rachman's insider trades
Ilya M Rachman is CEO and Chairman at Immix Biopharma (IMMX). Since Dec 20, 2021, Ilya has reported 8 open-market purchases worth $54K and no sales on SEC Form 4. In the last 12 months: 1 buy ($5K).
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMMX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.